For research use only. Not for therapeutic Use.
SKIV（Cat No.:I015527） is a highly potent noncompetitive inhibitor of nonlipid sphingosine kinase (SPHK) and phosphatidylinositol 3-kinase (PI3K). It demonstrates an IC50 value of 2 μM for GST-hSK and 6 μM for hPI3K, respectively. By inhibiting SPHK, SKIV effectively reduces the production of the mitotic second messenger sphingosine-1-phosphate (S1P). This compound exhibits apoptosis-inducing properties and displays antitumor activity. SKIV’s dual inhibition of SPHK and PI3K highlights its potential as a therapeutic agent in cancer research and the modulation of sphingolipid signaling pathways.
| Catalog Number | I015527 |
| CAS Number | 24418-86-8 |
| Molecular Formula | C₁₅H₁₀O₄ |
| Purity | ≥95% |
| Storage | 2-8°C |
| IUPAC Name | (2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-1-benzofuran-3-one |
| InChI | InChI=1S/C15H10O4/c16-11-6-5-9(7-12(11)17)8-14-15(18)10-3-1-2-4-13(10)19-14/h1-8,16-17H/b14-8- |
| InChIKey | HCBULGQMULJTCM-ZSOIEALJSA-N |
| SMILES | C1=CC=C2C(=C1)C(=O)C(=CC3=CC(=C(C=C3)O)O)O2 |
| Reference | [1]. French KJ, et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 2003 Sep 15;63(18):5962-9.<br>[2]. French KJ, et al. Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther. 2006 Aug;318(2):596-603. |
